Recently, an in vitro cell model identified the repressive effect of an ASO (AZD9150) on reducing signal transducer and activator of transcription 3 (STAT3) expression by directly targeting its transcripts, which exerts antitumor impacts on lung cancer and lymphomas (Table 2) [82]. The gene discussed is STAT3; the disease is lung carcinoma.